IDEXX Laboratories (IDXX) PT Raised to $160 at Piper Jaffray Following In-Line Q4; 'Neutral' Rating Maintained

February 2, 2015 7:23 AM

Piper Jaffray analyst Kevin Ellich raised his price target on IDEXX Laboratories (NASDAQ: IDXX) to $160.00 (from $129.00) following mostly ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found